A novel mAb broadly neutralizes SARS-CoV-2 VOCs in vitro and in vivo, including the Omicron variants.
Kan Q, Lin X, Li T, Ke X, Jian X, Hou L, Zhang W, Wan Z, Xie Q, Shao H, Ye L, Ye J, Qin A, Zou Z, Chen Q.
Kan Q, et al. Among authors: ye l, ye j.
J Med Virol. 2023 Mar;95(3):e28657. doi: 10.1002/jmv.28657.
J Med Virol. 2023.
PMID: 36912367